Current and historical daily PE Ratio for Syngen Biotech Co Ltd (
ROCO:8279
) from 2014 to Jun 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Syngen Biotech stock (ROCO:8279) PE ratio as of Jun 25 2024 is 16.58.
More Details
Syngen Biotech Co Ltd (ROCO:8279) PE Ratio (TTM) Chart
Syngen Biotech Co Ltd (ROCO:8279) PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Total 1227
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Syngen Biotech PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-25 | 16.6 | 2024-04-19 | 15.8 |
2024-06-24 | 16.6 | 2024-04-18 | 15.8 |
2024-06-21 | 16.8 | 2024-04-17 | 17.2 |
2024-06-20 | 16.7 | 2024-04-16 | 17.6 |
2024-06-19 | 16.3 | 2024-04-15 | 16.0 |
2024-06-18 | 16.2 | 2024-04-12 | 16.6 |
2024-06-17 | 16.2 | 2024-04-11 | 16.6 |
2024-06-14 | 16.1 | 2024-04-10 | 16.6 |
2024-06-13 | 16.4 | 2024-04-09 | 16.6 |
2024-06-12 | 16.4 | 2024-04-08 | 16.3 |
2024-06-11 | 16.2 | 2024-04-04 | 16.4 |
2024-06-07 | 16.4 | 2024-04-03 | 16.4 |
2024-06-06 | 16.4 | 2024-04-02 | 16.4 |
2024-06-05 | 16.6 | 2024-04-01 | 16.4 |
2024-06-04 | 16.3 | 2024-03-29 | 16.3 |
2024-06-03 | 16.1 | 2024-03-28 | 16.4 |
2024-05-31 | 16.0 | 2024-03-27 | 15.8 |
2024-05-30 | 15.8 | 2024-03-26 | 15.9 |
2024-05-29 | 15.7 | 2024-03-25 | 15.9 |
2024-05-28 | 16.1 | 2024-03-22 | 16.0 |
2024-05-27 | 15.8 | 2024-03-21 | 15.9 |
2024-05-24 | 15.5 | 2024-03-20 | 15.6 |
2024-05-23 | 15.8 | 2024-03-19 | 15.6 |
2024-05-22 | 15.4 | 2024-03-18 | 15.4 |
2024-05-21 | 15.8 | 2024-03-15 | 15.4 |
2024-05-20 | 17.4 | 2024-03-14 | 15.4 |
2024-05-17 | 15.8 | 2024-03-13 | 15.4 |
2024-05-16 | 15.8 | 2024-03-12 | 15.5 |
2024-05-15 | 16.0 | 2024-03-11 | 15.4 |
2024-05-14 | 16.1 | 2024-03-08 | 15.0 |
2024-05-13 | 16.1 | 2024-03-07 | 15.2 |
2024-05-10 | 16.1 | 2024-03-06 | 14.9 |
2024-05-09 | 15.6 | 2024-03-05 | 15.0 |
2024-05-08 | 15.4 | 2024-03-04 | 15.1 |
2024-05-07 | 15.5 | 2024-03-01 | 15.2 |
2024-05-06 | 15.5 | 2024-02-29 | 15.0 |
2024-05-03 | 15.5 | 2024-02-28 | 15.0 |
2024-05-02 | 15.7 | 2024-02-27 | 15.0 |
2024-04-30 | 15.5 | 2024-02-26 | 15.2 |
2024-04-29 | 16.0 | 2024-02-23 | 14.9 |
2024-04-26 | 16.0 | 2024-02-22 | 14.8 |
2024-04-25 | 16.6 | 2024-02-21 | 14.8 |
2024-04-24 | 15.8 | 2024-02-20 | 15.0 |
2024-04-23 | 15.8 | 2024-02-19 | 15.0 |
2024-04-22 | 15.8 | 2024-02-16 | 14.6 |
Syngen Biotech Co Ltd (ROCO:8279) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Syngen Biotech Co Ltd
ISIN : TW0008279001
Description
Syngen Biotech Co Ltd is a biotechnology company. It is engaged in the manufacturing, sales, and trading of microbial pharmaceutical raw materials. It also provides the design and development of health food and biochemical nutrition. The company's products include pharmaceutical ingredients, nutritional ingredients, biology fermentation products, biology agriculture and aquaculture products.